JUL 16, 2021 3:47 PM PDT

Machine Learning Ranks Cancer Drugs by Efficacy

WRITTEN BY: Annie Lennon

A machine learning algorithm developed by researchers at the Queen Mary University of London in the UK can rank cancer drugs based on how effective they are at reducing the growth of cancer cells. The results were published in Nature Communications

The researchers have called the algorithm 'Drug Ranking Using Machine Learning' (DRUML). Its models are based on datasets from analyses involving proteomics- the study of proteins inside cells- and phosphoproteomics- the study of how these proteins are modified- of 48 leukemia, esophagus, and liver cancer cell lines, and how they respond to 412 cancer drugs. 

From this data, DRUML was able to accurately rank the different drugs in order of effectiveness at reducing cancer cell growth. DRUML was also able to predict cytarabine sensitivity, a kind of chemotherapy, in those with clinical leukemia, and predict patient survival. 

The researchers cross-checked the algorithm's predictive accuracy with data from 12 other labs and a clinical dataset of 36 primary acute myeloid samples. 

As new drugs are developed in the future, the researchers behind DRUML say their algorithm could be retrained to pinpoint the most effective drugs for various cancers at any given time. 

"DRUML predicted drug efficacy in several cancer models and from data obtained from different laboratories and in a clinical dataset," said Pedro Cutillas, lead author of the study. "These are exciting results because previous machine learning methods have failed to accurately predict drug responses in verification datasets, and they demonstrate the robustness and wide applicability of our method."

Cancers vary greatly from patient to patient in terms of their genetic makeup and general characteristics, meaning that patients can respond very differently to different drugs. Machine learning methods such as DRUML could help doctors and researchers combine genetic markers with clinical and diagnostic information to identify optimal treatment options that are personalized to each patient. 

 

Sources: Nature CommunicationsEurekAlert

 

About the Author
  • Annie Lennon is a writer whose work also appears in Medical News Today, Psych Central, Psychology Today, and other outlets. When she's not writing, she is COO of Xeurix, an HR startup that assesses jobfit from gamified workplace simulations.
You May Also Like
NOV 29, 2021
Cancer
An Amino Acid Can Improve Radiation Therapy for Metastatic Brain Cancer
NOV 29, 2021
An Amino Acid Can Improve Radiation Therapy for Metastatic Brain Cancer
There are 20 different amino acids that the human body uses to generate proteins.  Amino acids form chains called p ...
DEC 05, 2021
Microbiology
Researchers Find a Lyme Disease Diagnostic & Treatment Target
DEC 05, 2021
Researchers Find a Lyme Disease Diagnostic & Treatment Target
Ticks that carry Lyme disease can be found in more and more places. If a tick is infected with the bacterium that causes ...
DEC 16, 2021
Immunology
Just Add Water: Super Stable Freeze-Dried COVID Vaccines
DEC 16, 2021
Just Add Water: Super Stable Freeze-Dried COVID Vaccines
  In the face of a viral threat with pandemic potential, developing a potent vaccine is just one half of the battle ...
DEC 16, 2021
Cancer
Age Matters! Young Adults May Need Different Cancer Therapies
DEC 16, 2021
Age Matters! Young Adults May Need Different Cancer Therapies
The incidence of various cancers, including multiple myeloma, colorectal, kidney, and pancreatic cancer, is steadily&nbs ...
DEC 22, 2021
Coronavirus
Which COVID vaccine and booster are right for me?
DEC 22, 2021
Which COVID vaccine and booster are right for me?
The 2-year anniversary of the COVID-19 pandemic, which began in December 2019, recently passed. It would not be overstat ...
JAN 20, 2022
Health & Medicine
Transverse Myelitis Listed as a Side Effect of AstraZeneca's Viral Vector COVID-19 Vaccine, Recommended for J&J's Vaccine
JAN 20, 2022
Transverse Myelitis Listed as a Side Effect of AstraZeneca's Viral Vector COVID-19 Vaccine, Recommended for J&J's Vaccine
After reviewing data, the European Medicines Agency (EMA) concludes there is a likely causal relationship between the UK ...
Loading Comments...